9 March 2026, Bangkok – B.GRIMM Pharma (Thailand) Ltd., led by Mr. Panya Kitcharoenkankul, Head of B.GRIMM Pharma, and Ms. Atichaporn Chanprasit, Head of Ethical Channel, donated medicines for the treatment of Pulmonary Arterial Hypertension (PAH) worth a total of THB 1,000,000 to Siriraj Hospital. This marks the second consecutive year of support since 2025. Prof. Yongyut Sirivatanauksorn, M.D., Ph.D, Director of Siriraj Hospital, graciously accepted the donation on behalf of the hospital.
Mr. Panya Kitcharoenkankul emphasized, “B.GRIMM Pharma believes that equitable access to high-quality treatment is fundamental to a good quality of life and a sustainable healthcare system. This continued donation reflects our vision ‘Compassionately Pioneering Health for All Lives’ and our commitment to alleviating the burden on patients and hospitals.”
Prof. Yongyut Sirivatanauksorn, M.D., Ph.D elaborated on the importance of managing Pulmonary Arterial Hypertension, that “most patients delay seeking medical care until symptoms negatively interfere with their daily routines. Although PAH cannot yet be cured, timely access to treatment enables patients to return to a life closer to normal, promotes health outcomes, and potentially increases life expectancy.”
“The medicine is developed and manufactured domestically in accordance with world-class standards and undergoes rigorous testing procedures for quality, safety, and efficacy to help reduce reliance on imported pharmaceuticals. B.GRIMM Pharma places great importance on minimizing disparities in access to treatment. We remain committed to supporting healthcare professionals and medical institutes in providing inclusive and equitable patient care,” added Ms. Atichaporn Chanprasit.
B.GRIMM Pharma continues to drive the development and delivery of high-quality pharmaceuticals and healthcare innovations nationwide. Through world-class standards and advanced technologies, the company aims to address the evolving health needs of society.
ไม่มีความคิดเห็น:
แสดงความคิดเห็น